Mikel García-Puga

534 citations
12 papers · 389 indexed · h-index 10

Mikel García-Puga

12 papers receiving 388 citations

Peers

Mikel García-Puga
Comparison fields: 5 of 55
  • Cellular and Molecular Neuroscience 157
  • Cancer Research 90
  • Neurology 66
  • Molecular Biology 294
  • Oncology 71
Replace Stéphanie Verbeke with:
Stéphanie Verbeke France
Aymeric Ravel‐Chapuis Canada
Gloria V. Echeverria United States
Svetlana Baranovskaya United States
Sana Sfar Tunisia
Emmanuelle Trinh France
Simona Dalin United States
Scott Ditch United States
Launce Gouw United States
Maja Sirotković-Skerlev Croatia
Mikel García-Puga relative to Stéphanie Verbeke France Stéphanie Verbeke's profile →
Citations per field
00.5×2.7×
Stéphanie Verbeke · 1×
Citations per year

Countries citing papers authored by Mikel García-Puga

Since Specialization
Citations

This map shows the geographic impact of Mikel García-Puga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikel García-Puga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikel García-Puga more than expected).

Fields of papers citing papers by Mikel García-Puga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikel García-Puga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikel García-Puga. The network helps show where Mikel García-Puga may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mikel García-Puga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mikel García-Puga Line = papers co-authored together Mikel García-Puga links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 202213
2 202214
3 202032
4 202036
5 20195
6 201817
7 201815
8 201696
9 201643
10
Paradoxical role of SOX2 in gastric cancer.
201639
11 20155
12 201574

About Mikel García-Puga

Mikel García-Puga is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Oncology, having authored 12 papers that have together received 389 indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (5 papers), Muscle Physiology and Disorders (4 papers), Mitochondrial Function and Pathology (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Cancer Cells and Metastasis (3 papers), Epigenetics and DNA Methylation (2 papers), MicroRNA in disease regulation (2 papers) and RNA modifications and cancer (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (157 citations), Cancer Research (90 citations) and Neurology (66 citations). Mikel García-Puga has collaborated with scholars based in Spain, United States and Brazil. Frequent co-authors include Ander Matheu, Adolfo López de Munaín, Estefanía Carrasco‐García, Roberto Fernández‐Torrón, Ander Saenz‐Antoñanzas, Marcos J. Araúzo‐Bravo, Juliana C. Santos, Paula Aldaz, María Goicoechea and Ana Aiastui. Their work appears in journals such as Neurology, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026